EDEN Insider Trading

Insider Ownership Percentage: 14.02%
Insider Buying (Last 12 Months): £1,052,198.10
Insider Selling (Last 12 Months): GBX 0

Eden Research Insider Trading History Chart

This chart shows the insider buying and selling history at Eden Research by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025100Mbought0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-50M050MTotal Insider BuyingTotal Insider Selling

Eden Research Share Price & Price History

Current Price: GBX 2.84
Price Change: Price Decrease of -0.114 (-3.86%)
As of 04/30/2025 10:50 AM ET

This chart shows the closing price history over time for EDEN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr2.99Closing price on 04/29/25:

Eden Research Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Eden Research (LON:EDEN)

52.79% of Eden Research stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Eden Research logo
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market: Based on plant-derived active ingredients, Mevalone ® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally. Cedroz ™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally. Eden's Sustaine ® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation. Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services. For more information about Eden, please visit: www.edenresearch.com .
Read More on Eden Research

Today's Range

Now: GBX 2.84
Low: 2.84
High: 3

50 Day Range

MA: GBX 2.85
Low: 2.37
High: 3.48

52 Week Range

Now: GBX 2.84
Low: 2.23
High: 5

Volume

219,718 shs

Average Volume

699,334 shs

Market Capitalization

£15.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Eden Research?

Eden Research's top insider investors include:
  1. Alexander John Abrey (Insider)
  2. Derek McAllan (Insider)
  3. Lykele van der Broek (Insider)
  4. Sean M Smith (Insider)
Learn More about top insider investors at Eden Research.